The largest database of trusted experimental protocols

Edc nhs

Manufactured by GE Healthcare
Sourced in United Kingdom

EDC/NHS is a coupling reagent used in the synthesis of peptides and conjugation of biomolecules. It facilitates the formation of amide bonds between carboxylic acids and primary amines. EDC (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) and NHS (N-Hydroxysuccinimide) work together to activate carboxylic acids for efficient coupling reactions.

Automatically generated - may contain errors

6 protocols using edc nhs

1

Kinetic Binding Analysis of Anti-Spike mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For kinetic binding measurements, the CM5 chip surface was activated by injecting a solution of EDC/NHS (GE Healthcare). Mouse anti-human IgG (Fc) mAb (25 μg/ml) was immobilized on the sensor chip by amine coupling, followed by deactivation using 1 M ethanolamine. Afterward, anti-spike mAbs (0.1 μg/ml) were then flowed over and captured on anti-human IgG (Fc) mAb-coated surface. Subsequently, gradient diluted his-tagged SARS-CoV-2 RBD solutions (1.875–30 nM, twofold serial dilution) were injected individually in a single-cycle kinetic format without regeneration (30 μl/min, association:180 s, dissociation:60 s). The binding data were double referenced by blank cycle and reference flow cell subtraction. Processed data were fitted by a 1:1 interaction model using Biacore T200 Evaluation Software 3.1.
+ Open protocol
+ Expand
2

Enzymatic Kinetics and Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
α-Glucosidase from yeast was purchased from Sigma-Aldrich (St. Louis, MO, USA). Acarbose (≥98%) and betulinic acid (≥98%) were obtained from Shanghai Yuanye Bio-Technology Co., Ltd. (Shanghai, China). p-Nitrophenyl-α-D-glucopyranoside (pNPG) were offered by Shanghai Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China). CM5 sensor chip, EDC/NHS and Amine Coupling Kit were purchased from GE Healthcare (Buckinghamshire, UK).
+ Open protocol
+ Expand
3

Sitagliptin-Target Protein Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the affinity and kinetics between sitagliptin and the novel target, we performed this experiment using Biacore T200 (GE Healthcare) instrument based on SPR, and used GraphPad Prism 8.0 software to visualize the data results (18 (link), 19 (link)).
Firstly, the amino acid sequence of the target protein was searched by Uniprot database, and the sequence was imported into Expasy (https://web.expasy.org/) website to calculate the isoelectric point of the protein (20 (link)). Then, the preconcentration experiment was carried out to determine the optimal coupling conditions. The target protein was coupled to CM5 chip (GE Healthcare) using the Immobilization module in Biacore T200 Control Software, and the reference channel was set to deduct the background. The chip was activated by EDC/NHS (GE Healthcare), and the uncoupling site was blocked by ethanolamine (GE Healthcare).
sitagliptin (HPLC ≥ 98%, Shanghai yuanye Bio-Technology Co., Ltd) was dissolved in DMSO (VWR) solution and diluted with PBS-P+ (GE Healthcare) solution to the desired compound concentration (1×PBS-P+, 5% DMSO). The affinity and kinetics of sitagliptin with the novel target protein were tested by LMW kinetics module in Biacore T200 Control Software, and extra wash after injection with 50% DMSO was added.
+ Open protocol
+ Expand
4

Biacore SPR Binding Kinetics Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biacore surface plasmon resonance experiments were performed at 25 ° C on a Biacore 3000 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). CC1 sensor surface was prepared using ligand thiol coupling, with the cysteine residue at the N terminus of CGG-CC1(233–342) (ref. 6 (link)). The immobilization was performed on a CM3 sensor chip at 5 μl min−1 flow rate with PBS (10 mM sodium phosphate pH 7.4, 150 mM NaCl). Flow cell was activated with 15 μl of EDC/NHS followed by 30 μl PDEA (GE Healthcare) to introduce a reactive disulfide group on the surface. Thirty microlitre of CC1 (10 μg ml−1 in 10 mM sodium acetate pH 5.5) was injected onto the activated surface and then blocked with 30 μl of cysteine-NaCl. Approximately 650 response units of CC1 were immobilized. A reference flow cell was prepared with activation and blocking steps, but without any protein coupled. Binding study was carried out at 50 μl min−1 flow rate using TBS (20 mM Tris, pH 7.0, 150 mM NaCl) containing 0.1% BSA (w/v) as running buffer. MBP-SOAR (0–16 μM, 2 × dilution) or MBP stock in TBS was first diluted twofold in TBS containing 0.2% BSA, then further diluted with running buffer and injected onto CC1 and reference surfaces. Background-corrected sensorgrams were collected and analysed using BIAevaluation (version 4.1).
+ Open protocol
+ Expand
5

Biacore Analysis of Sialyllactose Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measurements were performed on a Biacore™ T200 (GE-Healthcare Bio-Sciences AB) using CM5 chips, and running buffer HBSP (10 mM Hepes, 150 mM NaCl, 0.05% Tween 20, pH 7.4) at 25°C. Peptides and proteins were immobilized via amine coupling with EDC/NHS at a flow rate of 10 μl min-1, according to the manufacturer’s instructions (GE Healthcare). Optimum preconcentration was evaluated before, using acetate and phosphate buffers (10 mM) of pH 4 to 7, and ligand concentrations of 10 μg ml-1. For the immobilization of biotinylated sialyllactose (Lectinity), neutravidin (Thermo Fisher Scientific) (100 μg ml-1) was immobilized by amine coupling at pH 5.5 enabling high ligand density. Biotinylated sialyllactose was then injected at a concentration of 10 μg ml-1 in HBSP for 3 min.
+ Open protocol
+ Expand
6

Kinetic Binding of Anti-Spike mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For kinetic binding measurements, CM5 chip surface was activated by injecting a solution of EDC/NHS (GE Healthcare). Mouse anti-human IgG (Fc) mAb (25 μg/ml) was immobilized on the sensor chip by amine coupling, followed by deactivation using 1M ethanolamine. Afterward, anti-spike mAbs (0.1 μg/ml) were then flowed over and captured on anti-human IgG (Fc) mAb-coated surface. Subsequently, gradient diluted his-tagged SARS-CoV-2 RBD solutions (1.875 nM-30 nM, two-fold serial dilution) were injected individually in single-cycle kinetic format without regeneration (30 μl/min, association:180s, dissociation:60s). The binding data were double referenced by blank cycle and reference flow cell subtraction. Processed data were fitted by 1:1 interaction model using Biacore T200 Evaluation Software 3.1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!